BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19706886)

  • 1. Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.
    Verneris MR; Brunstein CG; Barker J; MacMillan ML; DeFor T; McKenna DH; Burke MJ; Blazar BR; Miller JS; McGlave PB; Weisdorf DJ; Wagner JE
    Blood; 2009 Nov; 114(19):4293-9. PubMed ID: 19706886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sources.
    Ballen KK; Joffe S; Brazauskas R; Wang Z; Aljurf MD; Akpek G; Dandoy C; Frangoul HA; Freytes CO; Khera N; Lazarus HM; LeMaistre CF; Mehta P; Parsons SK; Szwajcer D; Ustun C; Wood WA; Majhail NS
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1819-27. PubMed ID: 25064747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.
    Mehta RS; Holtan SG; Wang T; Hemmer MT; Spellman SR; Arora M; Couriel DR; Alousi AM; Pidala J; Abdel-Azim H; Ahmed I; Aljurf M; Askar M; Auletta JJ; Bhatt V; Bredeson C; Chhabra S; Gadalla S; Gajewski J; Gale RP; Gergis U; Hematti P; Hildebrandt GC; Inamoto Y; Kitko C; Khandelwal P; MacMillan ML; Majhail N; Marks DI; Mehta P; Nishihori T; Olsson RF; Pawarode A; Diaz MA; Prestidge T; Qayed M; Rangarajan H; Ringden O; Saad A; Savani BN; Seo S; Shah A; Shah N; Schultz KR; Solh M; Spitzer T; Szer J; Teshima T; Verdonck LF; Williams KM; Wirk B; Wagner J; Yared JA; Weisdorf DJ
    Blood Adv; 2019 May; 3(9):1441-1449. PubMed ID: 31053571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic cell transplantation for children with acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and umbilical cord blood versus marrow from HLA matched sibling donors.
    Smith AR; Baker KS; Defor TE; Verneris MR; Wagner JE; Macmillan ML
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1086-93. PubMed ID: 19660721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival.
    Kumar P; Defor TE; Brunstein C; Barker JN; Wagner JE; Weisdorf DJ; Burns LJ
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1394-400. PubMed ID: 19041062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation.
    Parkman R; Cohen G; Carter SL; Weinberg KI; Masinsin B; Guinan E; Kurtzberg J; Wagner JE; Kernan NA
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):919-27. PubMed ID: 16920557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia.
    Jacobsohn DA; Hewlett B; Ranalli M; Seshadri R; Duerst R; Kletzel M
    Bone Marrow Transplant; 2004 Nov; 34(10):901-7. PubMed ID: 15361908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.
    Eapen M; Rocha V; Sanz G; Scaradavou A; Zhang MJ; Arcese W; Sirvent A; Champlin RE; Chao N; Gee AP; Isola L; Laughlin MJ; Marks DI; Nabhan S; Ruggeri A; Soiffer R; Horowitz MM; Gluckman E; Wagner JE; ; ;
    Lancet Oncol; 2010 Jul; 11(7):653-60. PubMed ID: 20558104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unrelated Cord Blood Transplantation for Acute Leukemia Diagnosed in the First Year of Life: Outcomes and Risk Factor Analysis.
    Ruggeri A; Volt F; Locatelli F; Michel G; Diaz de Heredia C; Abecasis M; Zecca M; Vora A; Yakouben K; O'Brien TA; Giardino S; Cornish J; Rocha V; Peters C; Bader P; Gluckman E; Dalle JH
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):96-102. PubMed ID: 27777140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission.
    Page KM; Labopin M; Ruggeri A; Michel G; Diaz de Heredia C; O'Brien T; Picardi A; Ayas M; Bittencourt H; Vora AJ; Troy J; Bonfim C; Volt F; Gluckman E; Bader P; Kurtzberg J; Rocha V
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1350-1358. PubMed ID: 28438676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research-eurocord analysis.
    Weisdorf D; Eapen M; Ruggeri A; Zhang MJ; Zhong X; Brunstein C; Ustun C; Rocha V; Gluckman E
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):816-22. PubMed ID: 24582782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.
    Devillier R; Harbi S; Fürst S; Crocchiolo R; El-Cheikh J; Castagna L; Etienne A; Calmels B; Lemarie C; Prebet T; Granata A; Charbonnier A; Rey J; Chabannon C; Faucher C; Vey N; Blaise D
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1560-5. PubMed ID: 24933658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
    van Besien K; Hari P; Zhang MJ; Liu HT; Stock W; Godley L; Odenike O; Larson R; Bishop M; Wickrema A; Gergis U; Mayer S; Shore T; Tsai S; Rhodes J; Cushing MM; Korman S; Artz A
    Haematologica; 2016 May; 101(5):634-43. PubMed ID: 26869630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia.
    Ruggeri A; Labopin M; Sanz G; Piemontese S; Arcese W; Bacigalupo A; Blaise D; Bosi A; Huang H; Karakasis D; Koc Y; Michallet M; Picardi A; Sanz J; Santarone S; Sengelov H; Sierra J; Vincent L; Volt F; Nagler A; Gluckman E; Ciceri F; Rocha V; Mohty M; ;
    Leukemia; 2015 Sep; 29(9):1891-900. PubMed ID: 25882700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact on outcomes of human leukocyte antigen matching by allele-level typing in adults with acute myeloid leukemia undergoing umbilical cord blood transplantation.
    Sanz J; Jaramillo FJ; Planelles D; Montesinos P; Lorenzo I; Moscardó F; Martin G; López F; Martínez J; Jarque I; de la Rubia J; Larrea L; Sanz MA; Sanz GF
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):106-10. PubMed ID: 24516896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of graft source on unrelated donor hemopoietic stem cell transplantation in adults with acute myeloid leukemia after reduced-intensity or nonmyeloablative conditioning: a study from the Société Francaise de Greffe de Moelle et de Thérapie Cellulaire.
    Malard F; Milpied N; Blaise D; Chevallier P; Michallet M; Lioure B; Clément L; Hicheri Y; Cordonnier C; Huynh A; Yakoub-Agha I; Peffault de Latour R; Mohty M
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1059-67. PubMed ID: 25708220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia.
    Atsuta Y; Suzuki R; Nagamura-Inoue T; Taniguchi S; Takahashi S; Kai S; Sakamaki H; Kouzai Y; Kasai M; Fukuda T; Azuma H; Takanashi M; Okamoto S; Tsuchida M; Kawa K; Morishima Y; Kodera Y; Kato S;
    Blood; 2009 Feb; 113(8):1631-8. PubMed ID: 19104080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation.
    Baron F; Labopin M; Ruggeri A; Mohty M; Sanz G; Milpied N; Bacigalupo A; Rambaldi A; Bonifazi F; Bosi A; Sierra J; Yakoub-Agha I; Santasusana JM; Gluckman E; Nagler A
    J Hematol Oncol; 2015 Oct; 8():107. PubMed ID: 26445106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Umbilical Cord Blood Transplantation without Antithymocyte Globulin Results in Similar Survival but Better Quality of Life Compared with Unrelated Peripheral Blood Stem Cell Transplantation for the Treatment of Acute Leukemia-A Retrospective Study in China.
    Tong J; Xuan L; Sun Y; Huang D; Liu H; Zheng C; Zhu X; Tang B; Song K; Zhang X; Zhang L; Yao W; Lin D; Liu Q; Sun Z
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1541-1548. PubMed ID: 28499936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of a pilot study evaluating hyperbaric oxygen therapy to improve umbilical cord blood engraftment.
    Mina A; Shune L; Abdelhakim H; Lin TL; Ganguly S; Baran A; Singh A; Abhyankar S; McGuirk JP; Allin D; Aljitawi OS
    Ann Hematol; 2019 Feb; 98(2):481-489. PubMed ID: 30382305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.